{"id":968570,"date":"2026-05-29T08:04:20","date_gmt":"2026-05-29T12:04:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/"},"modified":"2026-05-29T08:04:20","modified_gmt":"2026-05-29T12:04:20","slug":"tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/","title":{"rendered":"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., May  29, 2026  (GLOBE NEWSWIRE) &#8212; Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that members of its executive team will present and participate in the upcoming Jefferies Global Healthcare Conference taking place from June 2-4, 2026, in New York, New York. Faraz Ali, Tenaya\u2019s Chief Executive Officer, will provide a company presentation on Thursday, June 4, 2026, at 3:10 p.m. ET.<\/p>\n<p>The live webcast of the presentation may be accessed from the Investors section of\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nqli1TLwnhIQlSkAKhtgr8805sANAXUh3tkV3vUp_DKiTBQoFxAl0OQd_P3CJdqO_HQ_IjTmQGf4hE1dhKvipFQmEdFTJR3TmydosVMaxw5yXo3Xzlb5zAlqL6F4qIOYFjQK2XiuqeloTadyukkKzp80SW9xjsavDR5BF1WX7KUnD7aNSIinvz48hXptpTqABribfHwouq5d5Zjhg6VqfnR2K_ZakrO7qYzztKmNgh9alP0rEMf_x-ZMLGaQz2FmtVIG-pOky-wZYKBdYtDi1SzjKqqt2Q4S_KDn2VOc7hcUPNzC6G9g6JY1XXv6arGJ-QEwwEdxlNgkAoeSKmTiCSGF3biDaPAZ7HZov_WPk0syEsQy5QPU5Mw-6UE2zTjVyMosJCwZ6V792hiWX5qViHqGg9TfwJIVHhHmd384PABC9siXWf28DsmixtaDSAWhCUNTKo8ESu6T1i1PLVZc5tvFT_eCJNRJzMq5clQHiHiNnQagB2qq5VrdZAA1pSguFGmKe__NjTF2aqAJTYuYexxM2ZHcJrCk8pgZGUxBFDhZok_gJ_z10pp0sgtK2fy20B92PEln1VRVgeN9zAR-IBVrlXZVMXcZeSO1AUElSfs=\" rel=\"nofollow\" target=\"_blank\">Tenaya\u2019s website<\/a>. An archived replay of the webcast will be available on the Tenaya website for approximately 30 days following the conference.<\/p>\n<p>\n        <strong>About\u00a0Tenaya Therapeutics<\/strong><br \/>\n        <br \/>Tenaya Therapeutics is a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. Tenaya\u2019s pipeline includes clinical-stage candidates TN-201, a gene therapy for\u00a0<em>MYBPC3<\/em>-associated hypertrophic cardiomyopathy (HCM); TN-401, a gene therapy for\u00a0<em>PKP2<\/em>-associated arrhythmogenic right ventricular cardiomyopathy (ARVC); and TN-301, a highly specific small molecule HDAC6 inhibitor with broad potential clinical utility in cardiac, metabolic and muscular conditions, including heart failure with preserved ejection fraction (HFpEF) and Duchenne muscular dystrophy (DMD). Tenaya has employed a suite of integrated internal capabilities including modality agnostic target discovery and validation, to generate a portfolio of novel medicines based on genetic insights, aimed at the treatment of both rare genetic disorders and more prevalent heart conditions. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Txs-H0MKUdEljcRIUS4wTSFF7MEo9Hdv6RE_YtZS3-FA_sAbBeUD-3045GamXJm-VTO7Tb5R7e4J8Q-PBbvF4_f7_0pGXwRhBCsWc5PDpaZGpFjZo4b--8jdAQPd2yCTDi6-Y6quMf3HcbErV8WPVSODHhQRaurwTfQV1uQuKkOoNzpdyBeiGjS9jMsYrSFzt-t8kjnDl09BxYpWfSyLCPDvtRdcvwMLXSt0q1UCogVz5n48wUkKEW8iB8Ll9QxjVo9xZRpBTflbrQoUK-au3BfRqAIEl1mtwlAHP1QltvE=\" rel=\"nofollow\" target=\"_blank\"><u>www.tenayatherapeutics.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Tenaya Contacts<\/strong><br \/>\n        <br \/>Michelle Corral<br \/>VP, Corporate Communications and Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RweaKqARkKD_WC4p1IEpgkBFCb0y-Z2wnIQDUWSekfGGfL_WYMY-Rzk8Pqo4QxHynHEQqBvb1sXp9ViMzoHXeetM-LiBFPquyssL2SrGXSYJZUOMtTR84C0JPjkKoBommwvsZhExiuRp93VnSmS1APuDJgpiJmJNmZYQKpM1eGL57_wp0WGi8hbjlgeQE8XtD6vnPLWzibaoO5wXsw_nUKu-AAkiOSoq8Ajr8TxMg7Fwxz11hH0hv3pfcLP9TIIwEDz584qJpVAVBtolUX41bA==\" rel=\"nofollow\" target=\"_blank\"><u>IR@tenayathera.com<\/u><\/a><\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Anne-Marie Fields<br \/>Precision AQ<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_wU_BJDV3YQpTHMw5DmHLFyxh6LXJwxzPTimzWruEUGzarJoqk06Bek2oC-OdbYCD8UC_bxjJ_60qbCNN7qATqc4kTqNKd1PlMJsvJ2ym9XzC_Tj8dIAxtahm844SoNsNWqprs70UvnRc6CPd5AUJQlLYVgn38L3-xGFjOzxjezkchmYuNuRv-z7sCJ-RYjxfwWuOyDugttkxIZSfhxVW__GLIKZEqyzMgIMc-EtzH0ssOpXix3q7pRcmc-lxJX6cBxMNQ3FE9SCKtxBEq40KVWm79s7-3o4y-dc9HyuP8rZIWajg64qwDDOR5EOPohnB4K4up6Hl6QDp_lhgs_ohQ==\" rel=\"nofollow\" target=\"_blank\"><u>annemarie.fields@precisionaq.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTJjYjNkZTQtZmZkNS00NDRiLTlkOWItYTJlZTBjM2ZjMjE0LTEyMjA5OTktMjAyNi0wNS0yOS1lbg==\/tiny\/Tenaya-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., May 29, 2026 (GLOBE NEWSWIRE) &#8212; Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that members of its executive team will present and participate in the upcoming Jefferies Global Healthcare Conference taking place from June 2-4, 2026, in New York, New York. Faraz Ali, Tenaya\u2019s Chief Executive Officer, will provide a company presentation on Thursday, June 4, 2026, at 3:10 p.m. ET. The live webcast of the presentation may be accessed from the Investors section of\u00a0Tenaya\u2019s website. An archived replay of the webcast will be available on the Tenaya website for approximately 30 days &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-968570","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., May 29, 2026 (GLOBE NEWSWIRE) &#8212; Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that members of its executive team will present and participate in the upcoming Jefferies Global Healthcare Conference taking place from June 2-4, 2026, in New York, New York. Faraz Ali, Tenaya\u2019s Chief Executive Officer, will provide a company presentation on Thursday, June 4, 2026, at 3:10 p.m. ET. The live webcast of the presentation may be accessed from the Investors section of\u00a0Tenaya\u2019s website. An archived replay of the webcast will be available on the Tenaya website for approximately 30 days &hellip; Continue reading &quot;Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-29T12:04:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026\",\"datePublished\":\"2026-05-29T12:04:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/\",\"name\":\"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=\",\"datePublished\":\"2026-05-29T12:04:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/","og_locale":"en_US","og_type":"article","og_title":"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., May 29, 2026 (GLOBE NEWSWIRE) &#8212; Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that members of its executive team will present and participate in the upcoming Jefferies Global Healthcare Conference taking place from June 2-4, 2026, in New York, New York. Faraz Ali, Tenaya\u2019s Chief Executive Officer, will provide a company presentation on Thursday, June 4, 2026, at 3:10 p.m. ET. The live webcast of the presentation may be accessed from the Investors section of\u00a0Tenaya\u2019s website. An archived replay of the webcast will be available on the Tenaya website for approximately 30 days &hellip; Continue reading \"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-29T12:04:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026","datePublished":"2026-05-29T12:04:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/","name":"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=","datePublished":"2026-05-29T12:04:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyODY0NiM3NjI3MTE1IzIyMDk0NDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=968570"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968570\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=968570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=968570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=968570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}